Reported Apr 29, 2015 · Terminated
Amphotericin B active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix…
Attix Pharmaceuticals
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Attix Pharmaceuticals · 184 Front St E · Toronto · N/A
Is this the product you have?
- Amphotericin B active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
- Lot codes and dates
- All lots repackaged and distributed between 01/05/12 to 02/12/15
- Amount recalled
- 5500 grams
This recall covers 470 products
The agency filed one notice per product. You are reading one of them; the other 469 are below.
457 more are in the archive.
Where it was sold
- Nationwide
Why it was recalled
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Attix Pharmaceuticals recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.